Meridian Holdings Inc./NV

(a)Form 8-K Information. The information and disclosures which are set forth above under “Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds”-“Recent sales of unregistered securities”, are incorporated by reference into this “Item 5. Other Information”, Section (a), in their entirety, and shall serve as disclosure of such information pursuant to Item 3.02 of Form 8-K.

The Company is voluntarily reporting the following information in this Part II, Item 5 of this Quarterly Report on Form 10-Q in lieu of reporting such information under Item 8.01 of a Current Report on Form 8-K. The information relates to an amendment entered into after the end of the fiscal quarter covered by this report and before the filing of this report:

On October 13, 2026, with effect from September 1, 2026, the Company and Igor Salindrija entered into Addendum No. 3 to the Igor Salindrija loan agreement. Under the amended terms, the parties acknowledged that the outstanding principal balance as of September 1, 2026 was EUR 550,000, and agreed to extend the repayment period through March 1, 2027 pursuant to a revised repayment schedule. Interest continues to accrue on the outstanding principal at an annual rate of 7%. Except as modified by Addendum No. 3, all other terms and conditions of the loan agreement, as previously amended by Addendum No. 1 and Addendum No. 2, remain unchanged.

(c) Rule 10b5-1 Trading Plans.

Our directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended September 30, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f)) adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”.